Lumen Bioscience is a biotechnology founded on April 1, 2017, operating out of Seattle, Washington, making an industrial molecular production platform using the blue-green algae Spirulina capable of producing valuable proteins and other molecules.
Lumen Bioscience is located in Seattle, Washington, and was founded by Brian Finrow and Jim Roberts on April 1, 2017. The biotechnology company is making a manufacturing platform for the mass production of the blue-green algae Spirulina (Arthrospira platensis) — an algae most well known for its use as a health supplement. Lumen Bioscience is using biotechnology tools to engineer strains of Spirulina to make commercially available high value proteins and other molecules for use in nutritional supplements, cosmetic, medical, and food products.
On December 5, 2017, Lumen Bioscience announced the company is receiving a grant from the US Department of Energy worth $1,800,000.
On December 5, 2017, Lumen Bioscience closed their series A funding round, raising $11,200,000 in capital from Bioeconomy Capital and Avista Development.